RA PHARMACEUTICALS, INC. (NASDAQ:RARX)
Historical Stock Chart
3 Months : From Nov 2017 to Feb 2018
Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage
biopharmaceutical company focusing on the development of next-generation
therapeutics for the treatment of complement-mediated diseases, today
announced that Doug Treco, Ph.D., President and Chief Executive Officer,
will participate in a fireside chat at the BMO Capital Markets
Prescriptions for Success Healthcare Conference on Thursday, December
14, 2017 at 3:30 p.m. E.T. The conference is being held at the Westin
New York Grand Central Hotel.
A live webcast of the presentation can be accessed by visiting the
investor relations section of the Company’s website, www.rapharma.com.
A replay of the presentation will also be available and archived on the
site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company
focusing on the development of next-generation therapeutics for
complement-mediated diseases. The Company discovers and develops
peptides and small molecules to target key components of the complement
cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171207005396/en/
Ra Pharmaceuticals, Inc.Investors:Jennifer Robinson,
PartnersEliza Schleifstein, firstname.lastname@example.org